Skip to main content
Results from an ongoing national quality improvement initiative examining adherence to American College of Cardiology (ACC) and American Heart Association (AHA) treatment guidelines for chest pain disorders, suggest that using a class of drugs known as glycoprotein (GP) IIb-IIIa inhibitors reduced in-hospital deaths by 46%.

Guidelines can reduce in-hospital deaths